Abstract
Editorials1 December 1986Controversies in the Management of ZollingerEllison SyndromeAARON I. VINIK, M.B., B.Ch., M.D., NORMAN THOMPSON, M.D.AARON I. VINIK, M.B., B.Ch., M.D.Search for more papers by this author, NORMAN THOMPSON, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-6-956 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe Zollinger-Ellison syndrome is characterized by persistent basal gastric acid hypersecretion due to hypergastrinemia. Death from fulminant ulcer disease is now rarely seen, and death from progression of the tumor has become the major issue. Management of nearly all patients with this disease was previously by total gastrectomy, and no attempt was made to identify or remove the source of gastrin hypersecretion. Over the 3 decades since the syndrome's description, there has been much debate as to the optimal form of management (1-3). Controversial areas include definition of subvarieties of the syndrome, each of which requires a different approach to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
